Cargando…

S1.2 The pediatrician and the early onset Pompe disease

Detalles Bibliográficos
Autores principales:	Fecarotta, Simona, Parenti, Giancarlo, Ascione, Serena, Montefusco, Giuseppe, Andria, Generoso
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2011
Materias:	Session 1. Pompe Disease: Clinical, Diagnostic and Genetic Aspects
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298099/

Ejemplares similares

S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011)

S1.3 Adult-onset Pompe disease
por: Di Iorio, Giuseppe, et al.
Publicado: (2011)

S1.5 Role of the pulmonologist in the late-onset Pompe disease
por: Fiorentino, Giuseppe, et al.
Publicado: (2011)

S1.4 Cardiovascular involvement in Pompe disease
por: Limongelli, Giuseppe, et al.
Publicado: (2011)

S1.1 Introductory notes to Pompe disease and aims of the Meeting
por: Sampaolo, Simone, et al.
Publicado: (2011)

Improvement of dysphagia in a child affected by Pompe disease treated with enzyme replacement therapy
por: Fecarotta, Simona, et al.
Publicado: (2013)

S1.6 Dry blood spot: a new method for early diagnosis
por: Donati, M.A.
Publicado: (2011)

S2.5 The nutritional approach to Pompe disease
por: Esposito, Katia, et al.
Publicado: (2011)

S2.3 Therapeutic approaches in the late onset form of GSD II
por: Musumeci, Olimpia, et al.
Publicado: (2011)

S2.4 The role of rehabilitation in the management of metabolic myopathies
por: Riccio, Ilaria, et al.
Publicado: (2011)

S2.1 Enzyme replacement therapy (ERT) in Glycogen Storage Disease Type II: the first treatment developed
por: Angelini, Corrado, et al.
Publicado: (2011)

The Pharmacological Chaperone N-butyldeoxynojirimycin Enhances Enzyme Replacement Therapy in Pompe Disease Fibroblasts
por: Porto, Caterina, et al.
Publicado: (2009)

Immune responses to alglucosidase in infantile Pompe disease: recommendations from an Italian pediatric expert panel
por: Gragnaniello, Vincenza, et al.
Publicado: (2022)

New treatments for the mucopolysaccharidoses: from pathophysiology to therapy
por: Fecarotta, Simona, et al.
Publicado: (2018)

Abnormal mannose-6-phosphate receptor trafficking impairs recombinant alpha-glucosidase uptake in Pompe disease fibroblasts
por: Cardone, Monica, et al.
Publicado: (2008)

Aortopathies in mouse models of Pompe, Fabry and Mucopolysaccharidosis IIIB lysosomal storage diseases
por: Belfiore, Maria Paola, et al.
Publicado: (2020)

Correction of oxidative stress enhances enzyme replacement therapy in Pompe disease
por: Tarallo, Antonietta, et al.
Publicado: (2021)

Genetic background of sinus node dysfunction requiring permanent pacemaker implantation after atrial fibrillation catheter ablation
por: Park, J W, et al.
Publicado: (2023)

Cardiogenetics and Artificial Intelligence: the Mutscore Algorithm
por: Porretta, A P, et al.
Publicado: (2023)

Familial cardiolaminopathy due to a previously undescribed LMNA gene mutation
por: Ibarra, R, et al.
Publicado: (2023)

Impact of mineralocorticoid receptor gene NRC2 on the prediction of arrhythmia after acute myocardial infarction
por: Daniulaityte, K, et al.
Publicado: (2023)

New insights into the correlation between genotype and cardiac phenotype in laminopathies
por: Dusi, V, et al.
Publicado: (2023)

Cardiac hereditary diseases: genetic insights from a single center 15-year experience
por: Porretta, A P, et al.
Publicado: (2023)

Update on rare variants in inherited arrhythmogenic syndromes: when to reclassify?
por: Martinez Barrios, E, et al.
Publicado: (2023)

Genotype-phenotype correlation of rare variants in the SCN5A gene in children population
por: Martinez Barrios, E, et al.
Publicado: (2023)

Orthostatic blood pressure recovery associates with physical performance, frailty and number of falls in geriatric outpatients
por: Mol, Arjen, et al.
Publicado: (2021)

Blood pressure characteristics of subclinical hypothyroidism: an observation study combined with office blood pressure and 24-h ambulatory blood pressure
por: Cai, Peng, et al.
Publicado: (2021)

Low-blood pressure phenotype underpins the tendency to reflex syncope
por: Brignole, Michele, et al.
Publicado: (2021)

Validity of five formulas in estimating 24-h urinary sodium via spot urine sampling in hypertensive patients living in Northeast China
por: Qian, Ni, et al.
Publicado: (2021)

The potential for overdiagnosis and underdiagnosis because of blood pressure variability: a comparison of the 2017 ACC/AHA, 2018 ESC/ESH and 2019 NICE hypertension guidelines
por: Bell, Katy, et al.
Publicado: (2021)

12 Observations from an inner city hospital during COVID-19: preterm birth rate and mode of delivery
por: Feldman, Kristina M., et al.
Publicado: (2021)

Blood Lactate Levels Cutoff and Mortality Prediction in Sepsis—Time for a Reappraisal? a Retrospective Cohort Study
por: Filho, Roberto Rabello, et al.
Publicado: (2016)

Pathogenesis of Mucopolysaccharidoses, an Update
por: Fecarotta, Simona, et al.
Publicado: (2020)

Respiratory manifestations in patients with inherited metabolic diseases
por: Santamaria, Francesca, et al.
Publicado: (2013)

Treatment Dilemma in Children with Late-Onset Pompe Disease
por: Faraguna, Martha Caterina, et al.
Publicado: (2023)

A Comprehensive Update on Late-Onset Pompe Disease
por: Labella, Beatrice, et al.
Publicado: (2023)

Sunday, May 11, 2008: Poster Session 1
Publicado: (2008)

Saturday, June 26, 2010: Poster Session 1
Publicado: (2010)

S3.1 Are there ERT defined guidelines for Pompe disease?
por: Toscano, Antonio, et al.
Publicado: (2011)

Ensuring continuity of care for children with inherited metabolic diseases at the time of COVID-19: the experience of a metabolic unit in Italy
por: Brunetti-Pierri, Nicola, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_n2fpma9a7hcghbtjfatp5vpgb0